Evidence map›Paper›PMID 26053549›Full record

ArticleScientific reports2015

Alpha or beta human chorionic gonadotropin knockdown decrease BeWo cell fusion by down-regulating PKA and CREB activation.

Sudha Saryu Malhotra, Pankaj Suman, Satish Kumar Gupta

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. The role of WNT10B in physiology and disease: A 10-year update.Frontiers in cell and developmental biology · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sudha Saryu MalhotraReproductive Cell Biology Laboratory, National Institute of Immunology, New Delhi-110 067, India.
Pankaj SumanAmity Institute of Biotechnology, Amity University, Sector-125, Noida, Uttar Pradesh-201 301, India.
Satish Kumar GuptaReproductive Cell Biology Laboratory, National Institute of Immunology, New Delhi-110 067, India.
National Institute of Immunology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study is to delineate the role of human chorionic gonadotropin (hCG) in trophoblast fusion. In this direction, using shRNA lentiviral particles, α- and β-hCG silenced 'BeWo' cell lines were generated. Treatment of both α- and β-hCG silenced BeWo cells with either forskolin or exogenous hCG showed a significant reduction in cell fusion as compared with control shRNA treated cells. Studies by qRT-PCR, Western blotting and immunofluorescence revealed down-regulation of fusion-associated proteins such as syncytin-1 and syndecan-1 in the α- and β-hCG silenced cells. Delineation of downstream signaling pathways revealed that phosphorylation of PKA and CREB were compromised in the silenced cells whereas, no significant changes in p38MAPK and ERK1/2 phosphorylation were observed. Moreover, β-catenin activation was unaffected by either α- or β-hCG silencing. Further, inhibition of PKA by H89 inhibitor led to a significant decrease in BeWo cell fusion but had no effect on β-catenin activation suggesting the absence of non-canonical β-catenin stabilization via PKA. Interestingly, canonical activation of β-catenin was associated with the up-regulation of Wnt 10b expression. In summary, this study establishes the significance of hCG in the fusion of trophoblastic BeWo cells, but there may be additional factors involved in this process.

Indexed as

beta CateninCell FusionChorionic Gonadotropin, beta Subunit, HumanColforsinCyclic AMP-Dependent Protein KinasesCyclic AMP Response Element-Binding ProteinDown-RegulationEnzyme ActivationExtracellular Signal-Regulated MAP KinasesGene Products, envGlycoprotein Hormones, alpha SubunitHumansIsoquinolinesp38 Mitogen-Activated Protein KinasesPhosphorylationPregnancy Proteinsbeta CateninCGA protein, humanChorionic Gonadotropin, beta Subunit, HumanColforsinCREB1 protein, humanCyclic AMP-Dependent Protein KinasesCyclic AMP Response Element-Binding ProteinExtracellular Signal-Regulated MAP KinasesGene Products, envGlycoprotein Hormones, alpha SubunitIsoquinolinesN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamidep38 Mitogen-Activated Protein KinasesPregnancy ProteinsProtein Kinase InhibitorsRNA, Small InterferingSDC1 protein, humanSulfonamidessyncytinSyndecan-1

Identifiers

PMID26053549
PMCPMC4459146
OpenAlexW584132653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.